By Josh White
Date: Thursday 13 Sep 2018
LONDON (ShareCast) - (Sharecast News) - Innovative medical technology designer and manufacturer Surgical Innovations Group updated the market on the CELLIS range of products supplied to its UK distribution business, Elemental Healthcare, by Meccellis Biotech on Thursday.
The AIM-traded firm said that on 12 September, Elemental received confirmation from Meccellis that CE certification had been issued in respect of the full range of CELLIS products previously sold by Elemental, and also covering new products including the CELLIS Breast Pocket range launched at the London Breast meeting on 6 & 7 September 2018.
It said the certificates were valid until August 2023.
"Meccellis are now in a position to resume manufacture of these products, and detailed plans are in progress to facilitate a timely and controlled reintroduction to the UK market in coming weeks," the Surgical Innovations board said in its statement.